CUE·22978P106·US·equity·Healthcare - Biotechnology-13D/G
CUE (CUE BIOPHARMA INC) is held by 27 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($244,800), BlackRock, Inc. ($103,261), STIFEL FINANCIAL CORP ($56,683). Net institutional sentiment: Mixed.
See how CUE's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer